To better reflect the effect of the combination of Romidepsin and Olaparib on HCC, we used an H11LNL-Myc mouse model that included a CAG promoter-loxp-STOP-loxp-Myc-polyA conditional overexpression structure in the H11 locus. Here, MYC is linked to hepatocellular carcinoma.